The Curbsiders Internal Medicine Podcast

#472 DIGEST: cfDNA & cancer in Pregnancy, Vitamin K2 for Leg Cramps, PRN anti-hypertensives, GLP-1 Agonists for AUD, Short-Course Antibiotics

Feb 24, 2025
Delve into the innovative world of non-invasive prenatal testing and its potential for early cancer detection in pregnant women. Discover the promising effects of Vitamin K2 for alleviating leg cramps and the dangers associated with as-needed antihypertensives in hospitals. Explore the use of GLP-1 agonists for treating alcohol use disorder and the effectiveness of short-course antibiotics for bacteremia. The discussion also highlights advancements in patient-collected HPV testing for cervical cancer screening, bringing attention to the future of accessible health care.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
INSIGHT

IDENTIFY Study Acronym

  • The IDENTIFY study's name is a contrived acronym for "Incidental Detection of Maternal Neoplasia through Non-Invasive Cell-free DNA Analysis."
  • It cleverly incorporates most letters from key study elements.
INSIGHT

Incidental Cancer Detection in NIPT

  • Non-invasive prenatal testing (NIPT) can incidentally detect maternal cancers through cell-free DNA analysis.
  • Current guidelines lack recommendations on managing non-reportable NIPT results.
INSIGHT

Cancers Found in IDENTIFY Study

  • The IDENTIFY study found cancers in almost 50% of pregnant women with non-reportable NIPT results.
  • These included lymphomas (mostly Hodgkin's) and solid tumors (colorectal, breast).
Get the Snipd Podcast app to discover more snips from this episode
Get the app